Global CMO and CDMO biotechnology Supply, Demand and Key Producers, 2024-2030
Page: 148
Published Date: 10 Feb 2024
Category: Service & Software
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global CMO and CDMO biotechnology market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global CMO and CDMO biotechnology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CMO and CDMO biotechnology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of CMO and CDMO biotechnology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CMO and CDMO biotechnology total market, 2019-2030, (USD Million)
Global CMO and CDMO biotechnology total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: CMO and CDMO biotechnology total market, key domestic companies and share, (USD Million)
Global CMO and CDMO biotechnology revenue by player and market share 2019-2024, (USD Million)
Global CMO and CDMO biotechnology total market by Type, CAGR, 2019-2030, (USD Million)
Global CMO and CDMO biotechnology total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global CMO and CDMO biotechnology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Patheon, Catalent, Samsung Biologics, Lonza., Boehringer Ingelheim, Samsung BioLogics, AGC Biologics, WuXi Biologics and AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CMO and CDMO biotechnology market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global CMO and CDMO biotechnology Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global CMO and CDMO biotechnology Market, Segmentation by Type
Service
Product
Platform/ Expression System
Global CMO and CDMO biotechnology Market, Segmentation by Application
Large Enterprise
SME
Companies Profiled:
Patheon
Catalent
Samsung Biologics
Lonza.
Boehringer Ingelheim
Samsung BioLogics
AGC Biologics
WuXi Biologics
AbbVie
Avid Bioservices
Fujifilm Diosynth Biotechnologies
KBI Biopharma (JSR Corporation)
Cytovance Biologics
Xpress Biologic
Rentschler Biopharma
Key Questions Answered
1. How big is the global CMO and CDMO biotechnology market?
2. What is the demand of the global CMO and CDMO biotechnology market?
3. What is the year over year growth of the global CMO and CDMO biotechnology market?
4. What is the total value of the global CMO and CDMO biotechnology market?
5. Who are the major players in the global CMO and CDMO biotechnology market?
Table of Contents
1 Supply Summary
1.1 CMO and CDMO biotechnology Introduction
1.2 World CMO and CDMO biotechnology Market Size & Forecast (2019 & 2023 & 2030)
1.3 World CMO and CDMO biotechnology Total Market by Region (by Headquarter Location)
1.3.1 World CMO and CDMO biotechnology Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States CMO and CDMO biotechnology Market Size (2019-2030)
1.3.3 China CMO and CDMO biotechnology Market Size (2019-2030)
1.3.4 Europe CMO and CDMO biotechnology Market Size (2019-2030)
1.3.5 Japan CMO and CDMO biotechnology Market Size (2019-2030)
1.3.6 South Korea CMO and CDMO biotechnology Market Size (2019-2030)
1.3.7 ASEAN CMO and CDMO biotechnology Market Size (2019-2030)
1.3.8 India CMO and CDMO biotechnology Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 CMO and CDMO biotechnology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CMO and CDMO biotechnology Major Market Trends
2.1 World CMO and CDMO biotechnology Consumption Value (2019-2030)
2.2 World CMO and CDMO biotechnology Consumption Value by Region
2.2.1 World CMO and CDMO biotechnology Consumption Value by Region (2019-2024)
2.2.2 World CMO and CDMO biotechnology Consumption Value Forecast by Region (2025-2030)
2.3 United States CMO and CDMO biotechnology Consumption Value (2019-2030)
2.4 China CMO and CDMO biotechnology Consumption Value (2019-2030)
2.5 Europe CMO and CDMO biotechnology Consumption Value (2019-2030)
2.6 Japan CMO and CDMO biotechnology Consumption Value (2019-2030)
2.7 South Korea CMO and CDMO biotechnology Consumption Value (2019-2030)
2.8 ASEAN CMO and CDMO biotechnology Consumption Value (2019-2030)
2.9 India CMO and CDMO biotechnology Consumption Value (2019-2030)
3.1 World CMO and CDMO biotechnology Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CMO and CDMO biotechnology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CMO and CDMO biotechnology in 2023
3.2.3 Global Concentration Ratios (CR8) for CMO and CDMO biotechnology in 2023
3.3 CMO and CDMO biotechnology Company Evaluation Quadrant
3.4 CMO and CDMO biotechnology Market: Overall Company Footprint Analysis
3.4.1 CMO and CDMO biotechnology Market: Region Footprint
3.4.2 CMO and CDMO biotechnology Market: Company Product Type Footprint
3.4.3 CMO and CDMO biotechnology Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4.1 United States VS China: CMO and CDMO biotechnology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CMO and CDMO biotechnology Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: CMO and CDMO biotechnology Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: CMO and CDMO biotechnology Consumption Value Comparison
4.2.1 United States VS China: CMO and CDMO biotechnology Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: CMO and CDMO biotechnology Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based CMO and CDMO biotechnology Companies and Market Share, 2019-2024
4.3.1 United States Based CMO and CDMO biotechnology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CMO and CDMO biotechnology Revenue, (2019-2024)
4.4 China Based Companies CMO and CDMO biotechnology Revenue and Market Share, 2019-2024
4.4.1 China Based CMO and CDMO biotechnology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CMO and CDMO biotechnology Revenue, (2019-2024)
4.5 Rest of World Based CMO and CDMO biotechnology Companies and Market Share, 2019-2024
4.5.1 Rest of World Based CMO and CDMO biotechnology Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CMO and CDMO biotechnology Revenue, (2019-2024)
5.1 World CMO and CDMO biotechnology Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Service
5.2.2 Product
5.2.3 Platform/ Expression System
5.3 Market Segment by Type
5.3.1 World CMO and CDMO biotechnology Market Size by Type (2019-2024)
5.3.2 World CMO and CDMO biotechnology Market Size by Type (2025-2030)
5.3.3 World CMO and CDMO biotechnology Market Size Market Share by Type (2019-2030)
6.1 World CMO and CDMO biotechnology Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Large Enterprise
6.2.2 SME
6.3 Market Segment by Application
6.3.1 World CMO and CDMO biotechnology Market Size by Application (2019-2024)
6.3.2 World CMO and CDMO biotechnology Market Size by Application (2025-2030)
6.3.3 World CMO and CDMO biotechnology Market Size by Application (2019-2030)
7.1 Patheon
7.1.1 Patheon Details
7.1.2 Patheon Major Business
7.1.3 Patheon CMO and CDMO biotechnology Product and Services
7.1.4 Patheon CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Patheon Recent Developments/Updates
7.1.6 Patheon Competitive Strengths & Weaknesses
7.2 Catalent
7.2.1 Catalent Details
7.2.2 Catalent Major Business
7.2.3 Catalent CMO and CDMO biotechnology Product and Services
7.2.4 Catalent CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Catalent Recent Developments/Updates
7.2.6 Catalent Competitive Strengths & Weaknesses
7.3 Samsung Biologics
7.3.1 Samsung Biologics Details
7.3.2 Samsung Biologics Major Business
7.3.3 Samsung Biologics CMO and CDMO biotechnology Product and Services
7.3.4 Samsung Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Samsung Biologics Recent Developments/Updates
7.3.6 Samsung Biologics Competitive Strengths & Weaknesses
7.4 Lonza.
7.4.1 Lonza. Details
7.4.2 Lonza. Major Business
7.4.3 Lonza. CMO and CDMO biotechnology Product and Services
7.4.4 Lonza. CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Lonza. Recent Developments/Updates
7.4.6 Lonza. Competitive Strengths & Weaknesses
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Details
7.5.2 Boehringer Ingelheim Major Business
7.5.3 Boehringer Ingelheim CMO and CDMO biotechnology Product and Services
7.5.4 Boehringer Ingelheim CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Boehringer Ingelheim Recent Developments/Updates
7.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.6 Samsung BioLogics
7.6.1 Samsung BioLogics Details
7.6.2 Samsung BioLogics Major Business
7.6.3 Samsung BioLogics CMO and CDMO biotechnology Product and Services
7.6.4 Samsung BioLogics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Samsung BioLogics Recent Developments/Updates
7.6.6 Samsung BioLogics Competitive Strengths & Weaknesses
7.7 AGC Biologics
7.7.1 AGC Biologics Details
7.7.2 AGC Biologics Major Business
7.7.3 AGC Biologics CMO and CDMO biotechnology Product and Services
7.7.4 AGC Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 AGC Biologics Recent Developments/Updates
7.7.6 AGC Biologics Competitive Strengths & Weaknesses
7.8 WuXi Biologics
7.8.1 WuXi Biologics Details
7.8.2 WuXi Biologics Major Business
7.8.3 WuXi Biologics CMO and CDMO biotechnology Product and Services
7.8.4 WuXi Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 WuXi Biologics Recent Developments/Updates
7.8.6 WuXi Biologics Competitive Strengths & Weaknesses
7.9 AbbVie
7.9.1 AbbVie Details
7.9.2 AbbVie Major Business
7.9.3 AbbVie CMO and CDMO biotechnology Product and Services
7.9.4 AbbVie CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 AbbVie Recent Developments/Updates
7.9.6 AbbVie Competitive Strengths & Weaknesses
7.10 Avid Bioservices
7.10.1 Avid Bioservices Details
7.10.2 Avid Bioservices Major Business
7.10.3 Avid Bioservices CMO and CDMO biotechnology Product and Services
7.10.4 Avid Bioservices CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Avid Bioservices Recent Developments/Updates
7.10.6 Avid Bioservices Competitive Strengths & Weaknesses
7.11 Fujifilm Diosynth Biotechnologies
7.11.1 Fujifilm Diosynth Biotechnologies Details
7.11.2 Fujifilm Diosynth Biotechnologies Major Business
7.11.3 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product and Services
7.11.4 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates
7.11.6 Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.12 KBI Biopharma (JSR Corporation)
7.12.1 KBI Biopharma (JSR Corporation) Details
7.12.2 KBI Biopharma (JSR Corporation) Major Business
7.12.3 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product and Services
7.12.4 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 KBI Biopharma (JSR Corporation) Recent Developments/Updates
7.12.6 KBI Biopharma (JSR Corporation) Competitive Strengths & Weaknesses
7.13 Cytovance Biologics
7.13.1 Cytovance Biologics Details
7.13.2 Cytovance Biologics Major Business
7.13.3 Cytovance Biologics CMO and CDMO biotechnology Product and Services
7.13.4 Cytovance Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Cytovance Biologics Recent Developments/Updates
7.13.6 Cytovance Biologics Competitive Strengths & Weaknesses
7.14 Xpress Biologic
7.14.1 Xpress Biologic Details
7.14.2 Xpress Biologic Major Business
7.14.3 Xpress Biologic CMO and CDMO biotechnology Product and Services
7.14.4 Xpress Biologic CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Xpress Biologic Recent Developments/Updates
7.14.6 Xpress Biologic Competitive Strengths & Weaknesses
7.15 Rentschler Biopharma
7.15.1 Rentschler Biopharma Details
7.15.2 Rentschler Biopharma Major Business
7.15.3 Rentschler Biopharma CMO and CDMO biotechnology Product and Services
7.15.4 Rentschler Biopharma CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Rentschler Biopharma Recent Developments/Updates
7.15.6 Rentschler Biopharma Competitive Strengths & Weaknesses
8.1 CMO and CDMO biotechnology Industry Chain
8.2 CMO and CDMO biotechnology Upstream Analysis
8.3 CMO and CDMO biotechnology Midstream Analysis
8.4 CMO and CDMO biotechnology Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World CMO and CDMO biotechnology Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World CMO and CDMO biotechnology Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World CMO and CDMO biotechnology Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World CMO and CDMO biotechnology Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World CMO and CDMO biotechnology Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CMO and CDMO biotechnology Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World CMO and CDMO biotechnology Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World CMO and CDMO biotechnology Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World CMO and CDMO biotechnology Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key CMO and CDMO biotechnology Players in 2023
Table 12. World CMO and CDMO biotechnology Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global CMO and CDMO biotechnology Company Evaluation Quadrant
Table 14. Head Office of Key CMO and CDMO biotechnology Player
Table 15. CMO and CDMO biotechnology Market: Company Product Type Footprint
Table 16. CMO and CDMO biotechnology Market: Company Product Application Footprint
Table 17. CMO and CDMO biotechnology Mergers & Acquisitions Activity
Table 18. United States VS China CMO and CDMO biotechnology Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China CMO and CDMO biotechnology Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based CMO and CDMO biotechnology Companies, Headquarters (States, Country)
Table 21. United States Based Companies CMO and CDMO biotechnology Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies CMO and CDMO biotechnology Revenue Market Share (2019-2024)
Table 23. China Based CMO and CDMO biotechnology Companies, Headquarters (Province, Country)
Table 24. China Based Companies CMO and CDMO biotechnology Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies CMO and CDMO biotechnology Revenue Market Share (2019-2024)
Table 26. Rest of World Based CMO and CDMO biotechnology Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CMO and CDMO biotechnology Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies CMO and CDMO biotechnology Revenue Market Share (2019-2024)
Table 29. World CMO and CDMO biotechnology Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World CMO and CDMO biotechnology Market Size by Type (2019-2024) & (USD Million)
Table 31. World CMO and CDMO biotechnology Market Size by Type (2025-2030) & (USD Million)
Table 32. World CMO and CDMO biotechnology Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World CMO and CDMO biotechnology Market Size by Application (2019-2024) & (USD Million)
Table 34. World CMO and CDMO biotechnology Market Size by Application (2025-2030) & (USD Million)
Table 35. Patheon Basic Information, Area Served and Competitors
Table 36. Patheon Major Business
Table 37. Patheon CMO and CDMO biotechnology Product and Services
Table 38. Patheon CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Patheon Recent Developments/Updates
Table 40. Patheon Competitive Strengths & Weaknesses
Table 41. Catalent Basic Information, Area Served and Competitors
Table 42. Catalent Major Business
Table 43. Catalent CMO and CDMO biotechnology Product and Services
Table 44. Catalent CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Catalent Recent Developments/Updates
Table 46. Catalent Competitive Strengths & Weaknesses
Table 47. Samsung Biologics Basic Information, Area Served and Competitors
Table 48. Samsung Biologics Major Business
Table 49. Samsung Biologics CMO and CDMO biotechnology Product and Services
Table 50. Samsung Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Samsung Biologics Recent Developments/Updates
Table 52. Samsung Biologics Competitive Strengths & Weaknesses
Table 53. Lonza. Basic Information, Area Served and Competitors
Table 54. Lonza. Major Business
Table 55. Lonza. CMO and CDMO biotechnology Product and Services
Table 56. Lonza. CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Lonza. Recent Developments/Updates
Table 58. Lonza. Competitive Strengths & Weaknesses
Table 59. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 60. Boehringer Ingelheim Major Business
Table 61. Boehringer Ingelheim CMO and CDMO biotechnology Product and Services
Table 62. Boehringer Ingelheim CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Boehringer Ingelheim Recent Developments/Updates
Table 64. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 65. Samsung BioLogics Basic Information, Area Served and Competitors
Table 66. Samsung BioLogics Major Business
Table 67. Samsung BioLogics CMO and CDMO biotechnology Product and Services
Table 68. Samsung BioLogics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Samsung BioLogics Recent Developments/Updates
Table 70. Samsung BioLogics Competitive Strengths & Weaknesses
Table 71. AGC Biologics Basic Information, Area Served and Competitors
Table 72. AGC Biologics Major Business
Table 73. AGC Biologics CMO and CDMO biotechnology Product and Services
Table 74. AGC Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. AGC Biologics Recent Developments/Updates
Table 76. AGC Biologics Competitive Strengths & Weaknesses
Table 77. WuXi Biologics Basic Information, Area Served and Competitors
Table 78. WuXi Biologics Major Business
Table 79. WuXi Biologics CMO and CDMO biotechnology Product and Services
Table 80. WuXi Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. WuXi Biologics Recent Developments/Updates
Table 82. WuXi Biologics Competitive Strengths & Weaknesses
Table 83. AbbVie Basic Information, Area Served and Competitors
Table 84. AbbVie Major Business
Table 85. AbbVie CMO and CDMO biotechnology Product and Services
Table 86. AbbVie CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. AbbVie Recent Developments/Updates
Table 88. AbbVie Competitive Strengths & Weaknesses
Table 89. Avid Bioservices Basic Information, Area Served and Competitors
Table 90. Avid Bioservices Major Business
Table 91. Avid Bioservices CMO and CDMO biotechnology Product and Services
Table 92. Avid Bioservices CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Avid Bioservices Recent Developments/Updates
Table 94. Avid Bioservices Competitive Strengths & Weaknesses
Table 95. Fujifilm Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 96. Fujifilm Diosynth Biotechnologies Major Business
Table 97. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product and Services
Table 98. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Fujifilm Diosynth Biotechnologies Recent Developments/Updates
Table 100. Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 101. KBI Biopharma (JSR Corporation) Basic Information, Area Served and Competitors
Table 102. KBI Biopharma (JSR Corporation) Major Business
Table 103. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product and Services
Table 104. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. KBI Biopharma (JSR Corporation) Recent Developments/Updates
Table 106. KBI Biopharma (JSR Corporation) Competitive Strengths & Weaknesses
Table 107. Cytovance Biologics Basic Information, Area Served and Competitors
Table 108. Cytovance Biologics Major Business
Table 109. Cytovance Biologics CMO and CDMO biotechnology Product and Services
Table 110. Cytovance Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Cytovance Biologics Recent Developments/Updates
Table 112. Cytovance Biologics Competitive Strengths & Weaknesses
Table 113. Xpress Biologic Basic Information, Area Served and Competitors
Table 114. Xpress Biologic Major Business
Table 115. Xpress Biologic CMO and CDMO biotechnology Product and Services
Table 116. Xpress Biologic CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Xpress Biologic Recent Developments/Updates
Table 118. Rentschler Biopharma Basic Information, Area Served and Competitors
Table 119. Rentschler Biopharma Major Business
Table 120. Rentschler Biopharma CMO and CDMO biotechnology Product and Services
Table 121. Rentschler Biopharma CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 122. Global Key Players of CMO and CDMO biotechnology Upstream (Raw Materials)
Table 123. CMO and CDMO biotechnology Typical Customers
List of Figure
Figure 1. CMO and CDMO biotechnology Picture
Figure 2. World CMO and CDMO biotechnology Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World CMO and CDMO biotechnology Total Market Size (2019-2030) & (USD Million)
Figure 4. World CMO and CDMO biotechnology Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World CMO and CDMO biotechnology Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company CMO and CDMO biotechnology Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company CMO and CDMO biotechnology Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company CMO and CDMO biotechnology Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company CMO and CDMO biotechnology Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company CMO and CDMO biotechnology Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company CMO and CDMO biotechnology Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company CMO and CDMO biotechnology Revenue (2019-2030) & (USD Million)
Figure 13. CMO and CDMO biotechnology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CMO and CDMO biotechnology Consumption Value (2019-2030) & (USD Million)
Figure 16. World CMO and CDMO biotechnology Consumption Value Market Share by Region (2019-2030)
Figure 17. United States CMO and CDMO biotechnology Consumption Value (2019-2030) & (USD Million)
Figure 18. China CMO and CDMO biotechnology Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe CMO and CDMO biotechnology Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan CMO and CDMO biotechnology Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea CMO and CDMO biotechnology Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN CMO and CDMO biotechnology Consumption Value (2019-2030) & (USD Million)
Figure 23. India CMO and CDMO biotechnology Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of CMO and CDMO biotechnology by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for CMO and CDMO biotechnology Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for CMO and CDMO biotechnology Markets in 2023
Figure 27. United States VS China: CMO and CDMO biotechnology Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: CMO and CDMO biotechnology Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World CMO and CDMO biotechnology Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World CMO and CDMO biotechnology Market Size Market Share by Type in 2023
Figure 31. Service
Figure 32. Product
Figure 33. Platform/ Expression System
Figure 34. World CMO and CDMO biotechnology Market Size Market Share by Type (2019-2030)
Figure 35. World CMO and CDMO biotechnology Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World CMO and CDMO biotechnology Market Size Market Share by Application in 2023
Figure 37. Large Enterprise
Figure 38. SME
Figure 39. CMO and CDMO biotechnology Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Patheon Catalent Samsung Biologics Lonza. Boehringer Ingelheim Samsung BioLogics AGC Biologics WuXi Biologics AbbVie Avid Bioservices Fujifilm Diosynth Biotechnologies KBI Biopharma (JSR Corporation) Cytovance Biologics Xpress Biologic Rentschler Biopharma
Related Reports
12 Jan 2023
Service & Software
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
